New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

about

Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments.Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death

P2860

Q55384335-50BBE8F4-512E-4DA2-A615-DBA3C7182FAD Q57283079-5C5B287D-B89C-4D05-9513-AC403EC77007

P2860

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q51839566

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

@en

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

@nl

type

Item

label

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

@en

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

@nl

prefLabel

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

@en

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

@nl

P1476

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

@en

P2093

Joanna Pierro

http://www.w3.org/2001/XMLSchema#string

Laura E Hogan

http://www.w3.org/2001/XMLSchema#string

Teena Bhatla

http://www.w3.org/2001/XMLSchema#string

William L Carroll

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Chimeric antigen receptor therapy for cancer

Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.

Childhood acute lymphoblastic leukemia: Integrating genomics into therapy

Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Chimeric antigen receptor T cells for sustained remissions in leukemia

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

P304

725-736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737140.2017.1347507

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28649891

http://www.w3.org/2001/XMLSchema#string

P932

6028000

http://www.w3.org/2001/XMLSchema#string

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

about

P2860

P2860

New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932